Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology(2023)

引用 7|浏览43
暂无评分
摘要
Our study demonstrates that baseline ctDNA detection is feasible and is prognostic in IR RMS.
更多
查看译文
关键词
tumor dna,oncology group,intermediate-risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要